Is Compass Therapeutics, Inc. (CMPX) a Buy, Sell, or Hold?
Compass Therapeutics, Inc.
NASDAQ:CMPX
$2.1291 USD
-$0.06 (-2.78%)
- Volume
- 426.36K
- Average Volume
- 8.15M
- Market Capitalization
- $294.43M
- P/E Ratio
- -5.01
- Dividend Yield
- 0.00%
- Price Target
- $11.00
- Year High
- $6.88
- Year Low
- $1.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.04
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-80.6% DOWNSIDE
$11.00 Price Target
UPSIDE/DOWNSIDE HIGH
-85.8% DOWNSIDE
$15.00 Price Target High
UPSIDE/DOWNSIDE LOW
-64.5% DOWNSIDE
$6.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Stephen Willey | $6 | $2.38 | 2026-06-01 07:32 AM | 152.1% |
| Jefferies | Maury Raycroft | $9 | $5.53 | 2026-03-05 04:33 PM | 62.7% |
| Raymond James | Sean McCutcheon | $9 | $4.891 | 2026-01-06 10:11 AM | 84.0% |
| JMP Securities | Reni Benjamin | $10 | $5.22 | 2025-12-03 05:02 AM | 91.6% |
| Leerink Partners | Andrew Berens | $6 | $1.69 | 2025-04-02 06:17 AM | 255.0% |
| Compass Point | Aydin Huseynov | $5 | $1.65 | 2024-09-16 02:49 AM | 203.0% |